Talaris Therapeutics is a late-clinical stage biotechnology company based in Boston, MA and Louisville, KY. Talaris is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe auto-immune and immune-mediated disorders.

Biotechnology

Talaris Therapeutics

Mary Kay Fenton

Yiming Huang

Jason Banta

Dillon Fairchild

Hong Xu

Ken Abrams

Talaris Therapeutics' Leadership Team includes Roderick Purdy and 12 others.

Leadership Team

Board of Directors

CEO and Executive Team

Leadership Team

About

Team members

Other teams at Talaris Therapeutics

Board of Directors

CEO and Executive Team